EpiBiome
South San Francisco
About EpiBiome
EpiBiome is a venture-backed precision microbiome engineering company tackling the challenge of antibiotic resistance by developing alternatives to small-molecule antibiotics for use in healthcare, veterinary and agriculture industries. Antibiotic-resistant bacteria surpass nuclear warfare, climate change, and terrorism as the biggest challenge facing humanity today. The pipeline of new antibiotics has slowed to a trickle, while the emergence of multi-drug resistant bacteria is on an unprecedented trajectory. These bacteria threaten to reverse more than 100 years of medical progress by making all but the most necessary surgical procedures too risky due to the threat of post-operative infection.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.1M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2017)
- Website: epibiome.com
- Phone: 650-825-1600
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/epibiome-76216 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.